First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Institute of Orthopaedics and Traumatology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, China.
Chin J Integr Med. 2018 Nov;24(11):806-808. doi: 10.1007/s11655-018-2930-x. Epub 2018 Apr 12.
As a traditional concept of Chinese medicine (CM), the theory of "Shen (Kidney) controlling bones" has been gradually proven. And in modern allopathic medicine, the multiple mechanisms of bone growth, development and regeneration align with the theory. Shen deficiency as a pathological condition has a negative effect on the skeleton of body, specifically the disorder of bone homeostasis. Present studies indicate that Shen deficiency shares a common disorder characterized by dysfunction of hypothalamic-pituitary-adrenal (HPA) axis. HPA axis may be an important regulator of bone diseases with abnormal homeostasis. Therefore, we posit the existence of hypothalamic-pituitary-adrenal-osteo-related cells axis: cells that comprise bone tissue (osteo-related cells) are targets under the regulation of HPA axis in disorder of bone homeostasis. Chinese herbs for nourishing Shen have potential in the development of treatments for disorder of bone homeostasis.
作为中医的一个传统概念,“肾(肾)控制骨骼”的理论逐渐得到证实。在现代西医学中,骨骼生长、发育和再生的多种机制与该理论一致。肾虚作为一种病理状态,对身体的骨骼有负面影响,特别是骨内稳态的紊乱。目前的研究表明,肾虚具有以下丘脑-垂体-肾上腺(HPA)轴功能障碍为特征的共同紊乱。HPA 轴可能是骨内稳态异常的骨疾病的重要调节剂。因此,我们假设存在下丘脑-垂体-肾上腺-骨相关细胞轴:在骨内稳态紊乱的情况下,组成骨骼组织(骨相关细胞)的细胞是 HPA 轴调节的靶标。补肾中药在骨内稳态紊乱治疗的发展中有一定的应用潜力。